Diagnosis and Treatment of Cold Agglutinin Disease

被引：0

作者：

Broome, Catherine M. ^{[1
]}

机构：

[1] MedStar Georgetown Univ Hosp, Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

来源：

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 03期

关键词：

RITUXIMAB;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：162 / 165

页数：4

共 4 条

[1] Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial [J].

Berentsen, Sigbjorn ;

Randen, Ulla ;

Oksman, Markku ;

Birgens, Henrik ;

Tvedt, Tor Henrik Anderson ;

Dalgaard, Jakob ;

Galteland, Eivind ;

Haukas, Einar ;

Brudevold, Robert ;

Sorbo, Jon Hjalmar ;

Naess, Inger Anne ;

Malecka, Agnieszka ;

Tjonnfjord, Geir E. .

BLOOD, 2017, 130 (04) :537-541

[2] High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease [J].

Berentsen, Sigbjorn ;

Randen, Ulla ;

Vagan, Anne Marita ;

Hjorth-Hansen, Henrik ;

Vik, Anders ;

Dalgaard, Jakob ;

Jacobsen, Eva-Marie ;

Thoresen, Aud S. ;

Beiske, Klaus ;

Tjonnfjord, Geir E. .

BLOOD, 2010, 116 (17) :3180-3184

[3]

Broome C, 2017, 59 ANN M AM SOC HEM

[4] Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial [J].

Roeth, Alexander ;

Bommer, Martin ;

Huettmann, Andreas ;

Herich-Terhuerne, Doerte ;

Kuklik, Nils ;

Rekowski, Jan ;

Lenz, Veronika ;

Schrezenmeier, Hubert ;

Duehrsen, Ulrich .

BLOOD ADVANCES, 2018, 2 (19) :2543-2549

← 1 →